ASO Author Reflections: Preoperative Prediction of Pathological Complete Response Using Deep Neural Network After Neoadjuvant Chemotherapy in Esophageal Cancer Patients-Reference-Cited by-同舟云学术

ASO Author Reflections: Preoperative Prediction of Pathological Complete Response Using Deep Neural Network After Neoadjuvant Chemotherapy in Esophageal Cancer Patients

Published:2023-07-13 Issue:12 Volume:30 Page:7509-7510
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Matsuda Satoru,Irino Tomoyuki,Okamura Akihiko,Mayanagi Shuhei,Booka Eisuke,Takeuchi Masashi,Kawakubo Hirofumi,Takeuchi Hiroya,Watanabe Masayuki,Kitagawa Yuko

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-023-13948-9.pdf

Reference4 articles.

1. Kato K, Ito Y, Daiko H, et al. A randomized controlled phase III trial comparing two chemotherapy regimen and chemoradiotherapy regimen as neoadjuvant treatment for locally advanced esophageal cancer, JCOG1109 NExT study. J Clin Oncol. 2022;40:238. https://doi.org/10.1200/JCO.2022.40.4_suppl.238

2. Matsuda S, Kitagawa Y, Takemura R, et al. Real-world evaluation of the efficacy of neoadjuvant DCF over CF in esophageal squamous cell carcinoma: propensity score matched analysis from 85 authorized institutes for esophageal cancer in Japan. Ann Surg. 2023;278:e35–e42. https://doi.org/10.1097/SLA.0000000000005533

3. Matsuda S, Yamamoto S, Kato K, et al. FRONTiER: A feasibility trial of nivolumab with neoadjuvant CF or DCF, FLOT therapy for locally advanced esophageal carcinoma (JCOG1804E)—short-term results for cohorts C and D. J Clin Oncol. 2022;40:286. https://doi.org/10.1200/JCO.2022.40.4_suppl.286

4. Matsuda S, Irino T, Okamura A, et al. Endoscopic evaluation of pathological complete response using deep neural network in esophageal cancer patients who received neoadjuvant chemotherapy -Multicenter retrospective study from four Japanese esophageal centers. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-13862-0.